Latest Ratios: P/E Ratio 164.0x · EV/EBITDA 23.4x · ROE 1.7%. (2018–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $4.3B | $6.1B | $3.6B | $2.0B | $1.2B | $2.2B | $1.6B | — | — |
| Enterprise Value | $5.1B | $6.9B | $4.1B | $2.6B | $2.0B | $3.0B | $3.2B | — | — |
| P/E Ratio → | 163.97 | 212.91 | — | — | — | — | — | — | — |
| P/S Ratio | 3.95 | 6.61 | 4.16 | 2.51 | 1.67 | 3.26 | — | — | — |
| P/B Ratio | 2.37 | 3.19 | 2.29 | 1.30 | 0.82 | 1.22 | — | — | — |
| P/FCF | 24.92 | 57.21 | 71.12 | 34.64 | 230.27 | — | 80.55 | — | — |
| P/OCF | 29.76 | 42.68 | 36.10 | 21.14 | 30.39 | 2420.71 | 39.97 | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 7.50 | 4.79 | 3.25 | 2.75 | 4.42 | — | — | — |
| EV / EBITDA | 23.36 | 36.61 | 23.53 | 18.49 | — | — | 46.07 | — | — |
| EV / EBIT | 98.75 | 92.63 | 144.12 | — | — | — | — | — | — |
| EV / FCF | — | 64.90 | 81.94 | 44.84 | 379.52 | — | 161.14 | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 47.4% | 47.4% | 46.7% | 44.5% | 44.2% | 42.5% | — | 42.8% | 37.9% |
| Operating Margin | 5.6% | 5.6% | 2.9% | -2.7% | -41.5% | -10.3% | — | 6.5% | -1.1% |
| Net Profit Margin | 3.1% | 3.1% | -4.2% | -12.1% | -38.6% | -33.3% | — | -27.7% | -23.4% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| ROE | 1.7% | 1.7% | -2.3% | -6.4% | -17.0% | -41.7% | — | -2690484.1% | -2204038.3% |
| ROA | 0.9% | 0.9% | -1.3% | -3.6% | -9.5% | -10.2% | -7.3% | -2440000.0% | -2074000.0% |
| ROIC | 1.6% | 1.6% | 0.9% | -0.7% | -9.3% | -3.0% | -0.4% | — | — |
| ROCE | 1.8% | 1.8% | 1.0% | -0.9% | -11.0% | -3.5% | -0.5% | 635130.7% | -99893.7% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.64 | 0.64 | 0.46 | 0.47 | 0.58 | 0.48 | — | — | — |
| Debt / EBITDA | 6.51 | 6.51 | 4.11 | 5.12 | — | — | 24.77 | — | — |
| Net Debt / Equity | — | 0.43 | 0.35 | 0.38 | 0.53 | 0.44 | — | -1.15 | -1.06 |
| Net Debt / EBITDA | 4.33 | 4.33 | 3.11 | 4.20 | — | — | 23.04 | -0.00 | -0.00 |
| Debt / FCF | — | 7.68 | 10.83 | 10.19 | 149.25 | — | 80.59 | — | -0.00 |
| Interest Coverage | 1.77 | 1.77 | 0.49 | -0.22 | -1.65 | -0.33 | — | — | — |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.83 | 2.83 | 2.26 | 2.03 | 1.97 | 2.05 | 2.12 | 7.86 | 16.95 |
| Quick Ratio | 2.34 | 2.34 | 1.75 | 1.48 | 1.38 | 1.49 | 1.63 | 7.86 | 16.95 |
| Cash Ratio | 1.33 | 1.33 | 0.69 | 0.50 | 0.32 | 0.40 | 0.65 | 7.86 | 16.95 |
| Asset Turnover | — | 0.26 | 0.33 | 0.29 | 0.26 | 0.21 | — | 88020.00 | 88820.00 |
| Inventory Turnover | 3.19 | 3.19 | 3.45 | 3.08 | 2.80 | 3.11 | — | — | — |
| Days Sales Outstanding | — | 114.38 | 107.41 | 105.00 | 114.72 | 119.99 | — | — | — |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 0.6% | 0.5% | — | — | — | — | — | — | — |
| FCF Yield | 4.0% | 1.7% | 1.4% | 2.9% | 0.4% | — | 1.2% | — | — |
| Buyback Yield | 1.2% | 0.8% | 0.1% | 0.0% | 0.0% | 0.0% | 0.0% | — | — |
| Total Shareholder Yield | 1.2% | 0.8% | 0.1% | 0.0% | 0.0% | 0.0% | 0.0% | — | — |
| Shares Outstanding | — | $261M | $205M | $196M | $181M | $208M | $145M | $20M | $95M |
Includes 30+ ratios · 8 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying MIR stock.
Mirion Technologies, Inc.'s current P/E ratio is 164.0x. This places it at the 50th percentile of its historical range.
Mirion Technologies, Inc.'s current EV/EBITDA is 23.4x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 31.2x.
Mirion Technologies, Inc.'s return on equity (ROE) is 1.7%. The historical average is -13.2%.
Based on historical data, Mirion Technologies, Inc. is trading at a P/E of 164.0x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Mirion Technologies, Inc. has 47.4% gross margin and 5.6% operating margin.
Mirion Technologies, Inc.'s Debt/EBITDA ratio is 6.5x, indicating high leverage. A ratio above 4x may signal elevated financial risk.
Key Metrics
Top Statement Risk
Near-zero ROIC against goodwill-heavy asset base
Metrics are mathematically derived from official filings.
Returns Stubbornly Below Cost of Capital
Mirion's ROIC of 0.5% in 2026Q3, as derived from the company's reported quarterly ratio data, remains near zero despite 7.5% revenue growth, suggesting the acquisition-built asset base—now roughly 54% goodwill—has yet to generate returns that plausibly clear a weighted average cost of capital.
The trend is less a decay than a persistent failure to launch: ROIC peaked at just 1.0% in 2024Q4 and has oscillated between 0.1% and 0.8% since, while ROE of 0.4% and ROA of 0.2% confirm the weakness is not capital-structure driven. Because total assets grew from $2.6B to $3.5B over the ten-quarter window largely through acquisitions, the denominator has expanded faster than the earnings numerator; the analytical question is whether this is a digestion phase that resolves into operating leverage, or a structural signal that the roll-up is not creating accounting or economic returns. Investors should track whether ROIC can reach mid-single digits without further M&A, which would suggest organic improvement rather than financial engineering.
Premium Gross Margin, Absent Operating Leverage
Gross margin held at 47.3% in 2026Q3, yet operating margin of 6.2% and net margin of 2.7% imply an approximately 41-point absorption of overhead and amortization; based on Mirion's reported figures, the gap has narrowed versus 2024Q3's negative operating margin but remains structurally wide.
The 47%+ gross margin is consistent with a regulated, certification-protected product set where pricing appears resilient, so the earnings constraint is clearly below the gross line. SG&A has remained in a 37–41% of revenue band across ten quarters even as revenue grew 24.5% year-over-year, which suggests overhead has scaled with the top line rather than being absorbed by it—undermining the usual acquisition-scale thesis. The truest read of earning power here is likely free cash flow margin (17.0% in 2026Q3) rather than the 2.7% net margin, since the latter is depressed by roughly $38M of quarterly amortization and lumpy stock compensation; both readings should be monitored for convergence, as persistent divergence would suggest reported earnings quality is the anomaly, not the cash flows.
Rapid Deleveraging, Thin Coverage
Debt-to-equity fell to 0.42 in 2026Q3 from 0.66 a quarter earlier, but interest coverage of 2.05x and Debt/EBITDA of 46.43x, as shown in the latest reported ratio table, indicate reported EBITDA remains thin relative to the $798.6M debt load despite the paydown.
The single-quarter drop from $1.2B to $798.6M of total debt is far larger than the quarter's roughly $47.3M of free cash flow would fund, so the deleveraging likely reflects either a refinancing, an equity-linked settlement, or an accounting reclassification rather than pure internal generation; the exact mechanism warrants verification in the next filing. Coverage is the more honest signal: interest coverage of 2.05x, having been as low as 0.01x in 2024Q3 and 0.38x in 2026Q1, shows debt service comfort is highly variable quarter to quarter and sensitive to seasonality in operating income. The extremely high trailing Debt/EBITDA reading likely reflects depressed trailing EBITDA rather than an absolute debt burden, but on reported figures the company should be characterized as modestly levered with unreliable coverage rather than conservatively financed.
Multiple Prices Inflection Not Yet Visible
At a trailing P/E of 140.09x and EV/EBITDA of 24.21x, versus OSI Systems' 23.07x and 14.89x respectively, Mirion's valuation appears to price a margin inflection that trailing 3.1% net margins have not yet confirmed, based on current market pricing and peer comparables.
The gap between trailing (24.21x) and forward (14.05x) EV/EBITDA is the crux: the market is effectively underwriting roughly 70% EBITDA growth, which requires both revenue momentum and genuine overhead absorption, neither of which has been demonstrated on a sustained basis. Versus Envista (1.28x P/B) and OSI Systems (3.63x), Mirion's 2.10x P/B sits mid-range, which looks reasonable only if the $1.9B of goodwill survives impairment testing intact. The skipped guidance at the October 2026 earnings report reduces visibility into whether the forward multiple is achievable, so investors should treat the 28.27x forward P/E as an unverified consensus construct rather than a management-supported outlook; any deceleration from the 7.5% growth rate would leave the trailing multiples exposed.
Ample Current Cover, Heavy Inventory Float
Mirion's current ratio of 3.02 and quick ratio of 2.49 in 2026Q3 sit well above the 2.16 current ratio of two years prior, with $408.7M of cash against $798.6M of total debt as disclosed in the company's quarterly balance sheet.
Liquidity appears comfortable in isolation and above the 2.04–2.38 current ratio range of the selected peer group, giving the company meaningful buffer against a demand interruption or an input-cost spike in specialized detector materials. However, the quick ratio's closeness to the current ratio understates the real conversion profile: with days inventory outstanding at 100 days and a cash conversion cycle of 137 days, a substantial portion of the current asset base is inventory tied to long-cycle nuclear and oncology projects that may not liquidate quickly under stress. The 137-day cycle has improved from 183 days in 2025Q3, which appears to reflect better working capital discipline, but given the historical quarter-to-quarter swings of 20-plus days, investors should not assume the improvement is durable.
EV/EBITDA Misreads Acquisition Accounting
EV/EBITDA is the ratio most often misapplied here: Mirion's 24.21x trailing multiple rests on EBITDA inflated by roughly $38M of quarterly depreciation and amortization add-backs, most of it purchase accounting; as reported in filings, P/FCF of 35.27x offers a less distorted read.
Because cumulative ten-quarter operating cash flow of $373.5M compares with only $29.2M of cumulative net income, and that gap is almost entirely explained by $377.4M of aggregate D&A, EBITDA here is largely an artifact of how the acquisitions were booked rather than a measure of cash operating performance. The correct adjustment is to compare enterprise value against EBITDA less stock-based compensation (which at $14.0M in 2026Q3 exceeded net income) and against normalized free cash flow, since capex of roughly $10M per quarter means most of the D&A add-back is intangible amortization with no cash replacement requirement—but also no economic contribution. A secondary misapplication is ROE: with equity of $1.8B carried heavily at intangible book value and an accumulated deficit of $501.0M, a 0.4% ROE flatters no one and obscures that the real return question is ROIC against a hard-to-value, goodwill-dominated invested capital base.